2019 Safety Technology 
Online Laser Training
DECEMBER 8, 2019
Dr Godfrey Town gave a talk on ‘ Update on Home-Use Devices: New Devices, Regulations & Safety ’ as an Invited Speaker at the new European Congress on Advanced Treatments and Technologies in Skin & Aesthetics (Skin-Med2019) annual conference held 5th to 8th December 2019 at the Holton Munich City Hotel in Germany.
Online Laser Training
DECEMBER 8, 2019
Dr Godfrey Town gave a talk on ‘ Update on Home-Use Devices: New Devices, Regulations & Safety ’ as an Invited Speaker at the new European Congress on Advanced Treatments and Technologies in Skin & Aesthetics (Skin-Med2019) annual conference held 5th to 8th December 2019 at the Holton Munich City Hotel in Germany.
Online Laser Training
DECEMBER 8, 2019
Dr Godfrey Town gave a talk on ‘ Update on Home-Use Devices: New Devices, Regulations & Safety ’ as an Invited Speaker at the new European Congress on Advanced Treatments and Technologies in Skin & Aesthetics (Skin-Med2019) annual conference held 5th to 8th December 2019 at the Holton Munich City Hotel in Germany.
Lipgloss and Aftershave
NOVEMBER 1, 2024
CO2 Laser and Other Laser Treatments: Ablative and Non-Ablative Laser technology targets pigmentation by concentrating on melanin within the skin. Sequence Treatments for Safety: Estheticians can schedule less invasive treatments first and reserve higher-intensity therapies for later sessions to reduce skin sensitization. Draelos, Z.,
The Eco Well Blog
SEPTEMBER 18, 2022
Her company, Personal Care Regulatory offers comprehensive compliance using the latest technology (cloud based) software with a team of experts (toxicologist, claims substantiation specialist), providing end-to-end support for growing brands. There, he led the Product Safety group for 25 years. part of the Kao Group) in 1992.
The Eco Well Blog
MAY 8, 2023
John retired as Managing Director of Eurofins | Dermatest based in Sydney, Australia in June 2019, but remains in a part time consultancy role, specialising in sunscreens. He’s held key R&D, regulatory, quality, product safety, clinical & scientific affairs positions at Ciba, Dial, Henkel, ITG Brands, Newell Rubbermaid.
The Dermatology Digest
AUGUST 13, 2024
Nemolizumab was granted Breakthrough Therapy Designation in December 2019 and Priority Review in February 2024 by the U.S. The phase III OLYMPIA 1 and OLYMPIA 2 clinical trials evaluated the efficacy and safety of nemolizumab administered subcutaneously every four weeks in more than 500 patients with prurigo nodularis.
Expert insights. Personalized for you.
60 
Let's personalize your content